Psychosomatic Medicine, Vol 58, Issue 4 302-313, Copyright © 1996 by American Psychosomatic Society

ORIGINAL ARTICLES

Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic

JL Abelson, RM Nesse, JG Weg and GC Curtis
Department of Psychiatry, University of Michigan, Ann Arbor, USA.

The goals of this study were to: a) confirm prior evidence that the respiratory stimulant doxapram induces panic attacks and produces excessive hyperventilation in patients with panic disorder and b) explore the impact of cognitive mediators on symptom and respiratory responses. METHOD: Thirty-two subjects (16 patients and 16 controls) received doxapram (0.5 mg/kg) and placebo infusions while symptom, respiratory, and heart rate responses were monitored. Subjects were randomly assigned to receive either a standard introduction or a cognitive intervention designed to reduce the panic responses of panic patients to laboratory challenges. RESULTS: Doxapram was a potent and specific panicogenic agent, inducing panic in 75% of patients and 12.5% of controls. Compared with controls, patients also showed a greater decrease in end tidal carbon dioxide (CO2) and greater increases in minute ventilation, respiratory frequency, and heart rate. The cognitive intervention substantially attenuated the excessive hyperventilatory response of patients but did not fully normalize their breathing patterns. Tidal volume was the only respiratory measure not significantly altered by the cognitive intervention. CONCLUSIONS: In patients with panic disorder, doxapram (0.5 mg/kg) triggers panic attacks about as potently as 7% CO2 and more potently than 5% CO2 or lactate. Psychological factors can modulate the appearance of ventilatory abnormalities in panic patients, but persistent respiratory disturbances were still seen. Psychological factors and respiratory physiology both appear to be important phenomena in laboratory panic.

This article has been cited by other articles:

				R. Komatsu, P. Sengupta, G. Cherynak, A. Wadhwa, D. I. Sessler, J. Liu, H. E. Hurst, and R. Lenhardt Doxapram Only Slightly Reduces the Shivering Threshold in Healthy Volunteers Anesth. Analg., November 1, 2005; 101(5): 1368 - 1373. [Abstract] [Full Text] [PDF]

				J. L. Abelson, I. Liberzon, E. A. Young, and S. Khan Cognitive Modulation of the Endocrine Stress Response to a Pharmacological Challenge in Normal and Panic Disorder Subjects Arch Gen Psychiatry, June 1, 2005; 62(6): 668 - 675. [Abstract] [Full Text] [PDF]

				D. S. Pine, R. G. Klein, R. Roberson-Nay, S. Mannuzza, J. L. Moulton III, G. Woldehawariat, and M. Guardino Response to 5% Carbon Dioxide in Children and Adolescents: Relationship to Panic Disorder in Parents and Anxiety Disorders in Subjects Arch Gen Psychiatry, January 1, 2005; 62(1): 73 - 80. [Abstract] [Full Text] [PDF]

				I. Van Diest, S. Vuerstaek, I. Corne, S. De Peuter, S. Devriese, K. P. Van de Woestijne, and O. Van den Bergh Resting End-Tidal CO2 and Negative Affectivity Psychosom Med, November 1, 2003; 65(6): 976 - 983. [Abstract] [Full Text] [PDF]

				D. S. Pine, J. D. Coplan, L. A. Papp, R. G. Klein, J. M. Martinez, P. Kovalenko, N. Tancer, D. Moreau, E. S. Dummit III, D. Shaffer, et al. Ventilatory Physiology of Children and Adolescents With Anxiety Disorders Arch Gen Psychiatry, February 1, 1998; 55(2): 123 - 129. [Abstract] [Full Text] [PDF]